COVID-19 Human IgG PharmaGenie ELISA Kit (NP/S1 RBD) (SBRS1732)

This Indirect ELISA from Assay Genie is engineered for the qualitative and semi-quantitative detection of human IgG antibodies directed against SARS-CoV-2. The plate is pre-coated with two immunodominant viral antigens—the nucleoprotein (NP) and the Spike protein receptor-binding domain (S1 RBD)—enabling broad coverage of the humoral immune response following natural infection or vaccination.

The workflow accommodates flexible sample collection by accepting dried blood spots, plasma, saliva, and serum, with a recommended sample volume of 10 uL per well.

Each kit contains a pre-coated 96-well microplate, detection antibody, calibrators, wash buffer, TMB substrate solution, and stop reagent—sufficient for 96 individual determinations. Intended for in vitro research use only, this serological tool supports epidemiological surveillance, vaccine immunogenicity studies, and convalescent serum screening in laboratory settings.